[Renin-angiotensin system blockers and COVID-19 infection].
作者信息
Ruilope L M, Garcia Donaire J A, de la Sierra A
机构信息
Cardiorenal Translational Laboratory, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, España; Unidad de Hipertensión, Hospital Universitario 12 de Octubre, Madrid, España; Universidad Europea Madrid, Madrid, España; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, España.
Unidad de Hipertensión Arterial, Hospital Clínico San Carlos, Madrid, España; Unidad de Hipertensión. Servicio de Medicina Interna, Hospital Mutua Terrassa, Terrassa, Barcelona, España.
出版信息
Hipertens Riesgo Vasc. 2020 Jul-Sep;37(3):99-100. doi: 10.1016/j.hipert.2020.04.002. Epub 2020 Apr 16.
Abstract
摘要
相似文献
1
[Renin-angiotensin system blockers and COVID-19 infection].[肾素-血管紧张素系统阻滞剂与新型冠状病毒肺炎感染]
Hipertens Riesgo Vasc. 2020 Jul-Sep;37(3):99-100. doi: 10.1016/j.hipert.2020.04.002. Epub 2020 Apr 16.
2
Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.肾素-血管紧张素系统抑制剂在 COVID-19 大流行期间高血压管理中的应用。
J Physiol Pharmacol. 2020 Apr;71(2). doi: 10.26402/jpp.2020.2.01. Epub 2020 Jul 2.
3
Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.2019冠状病毒病大流行期间肾素-血管紧张素系统阻滞剂的使用：早期指南及不断演变的证据
Can J Cardiol. 2020 Aug;36(8):1180-1182. doi: 10.1016/j.cjca.2020.05.033. Epub 2020 Jun 2.
4
Drugs acting on renin angiotensin system and use in ill patients with COVID-19.作用于肾素-血管紧张素系统的药物及其在 COVID-19 重症患者中的应用。
Therapie. 2020 Jul-Aug;75(4):319-325. doi: 10.1016/j.therap.2020.05.009. Epub 2020 May 20.
5
Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.肾素-血管紧张素系统抑制剂对新型冠状病毒肺炎中2019冠状病毒感染及肺损伤的潜在差异影响
Hypertens Res. 2020 Aug;43(8):837-840. doi: 10.1038/s41440-020-0478-1. Epub 2020 May 20.
6
Drugs and the renin-angiotensin system in covid-19.新冠病毒肺炎中的药物与肾素-血管紧张素系统
BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313.
7
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.肾素-血管紧张素系统阻滞剂与 COVID-19 大流行：目前尚无证据表明应放弃使用肾素-血管紧张素系统阻滞剂。
Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25.
8
Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.关于在新冠疫情背景下成人和儿童使用肾素-血管紧张素系统降压阻滞剂的考量
Bol Med Hosp Infant Mex. 2020;77(5):274-281. doi: 10.24875/BMHIM.20000158.
9
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
10
The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic.冠状病毒感染中的肾素-血管紧张素-醛固酮系统——大流行期间的当前思考
J Cardiothorac Vasc Anesth. 2020 Jul;34(7):1717-1719. doi: 10.1053/j.jvca.2020.04.010. Epub 2020 Apr 16.
本文引用的文献
1
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
2
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.2019冠状病毒病（COVID-19）感染与肾素-血管紧张素系统阻滞剂
JAMA Cardiol. 2020 Jul 1;5(7):745-747. doi: 10.1001/jamacardio.2020.1282.
3
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
4
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.肾素-血管紧张素系统阻滞剂与 COVID-19 大流行：目前尚无证据表明应放弃使用肾素-血管紧张素系统阻滞剂。
Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25.
5
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
6
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
7
Preventing a covid-19 pandemic.预防新冠疫情。
BMJ. 2020 Feb 28;368:m810. doi: 10.1136/bmj.m810.
8
Effect of Renin-Angiotensin System Blockage in Patients with Acute Respiratory Distress Syndrome: A Retrospective Case Control Study.肾素-血管紧张素系统阻断对急性呼吸窘迫综合征患者的影响：一项回顾性病例对照研究。
Korean J Crit Care Med. 2017 May;32(2):154-163. doi: 10.4266/kjccm.2016.00976. Epub 2017 May 31.
9
Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂相关肺炎风险：系统评价和荟萃分析。
BMJ. 2012 Jul 11;345:e4260. doi: 10.1136/bmj.e4260.
Zotero 插件